DEPO‑MEDROL 40 mg


Suspension for injection
scheduling status
S4
registration number
C726 (Act 101/1965)
What DEPO‑MEDROL 40 mg contains
Methylprednisolone acetate.
other ingredients
Polyethylene glycol Sodium chloride Myristyl‑gamma‑picolinium chloride Water for injection Excipients with Known Effect None stated (sugar‑free).
Therapeutic classification
H02AB04 - description: H – Systemic hormonal preparations, excluding sex hormones and insulins H02 – Corticosteroids for systemic use H02A – Corticosteroids for systemic use, plain H02AB – Glucocorticoids H02AB04 – Methylprednisolone.
© 2026 SAHPRA. ALL RIGHTS RESERVED